Cargo Breaking News
FedEx Express has unveiled its ‘FedEx Life Science Center’ in Mumbai, setting a benchmark in the clinical trial supply chain in India and globally. The new capability will meet and support the clinical trial storage and logistics requirements of healthcare customers both within the India market and those shipping to India from around the world. The facility has ensured compliance with quality and regulatory requirements of the healthcare industry.
Key features of the new FedEx Life Science Center include:
· Covering all three temperature-controlled zones
o Controlled Ambient (15°C to 25°C)
o Refrigerated (2°C to 8°C)
o Frozen -20°C and Deep Frozen -80°C
· 24/7 monitoring and alarms for immediate response and intervention.
· Destruction services for returned Investigational Medicinal Products (IMPs).
· Equipped with document storage and a secure archival facility with fire-safe walls.
· Quality management system compliance to
o Good Clinical Practice (GCP)
o Good Distribution Practice (GDP)
· Use of gel pack and dry ice for secure packing and replenishment.
· Backup power generator
· Implementation of Good Manufacturing Practice (GMP) standards in labeling and validated packaging solutions.
· A centralized monitoring system to ensure temperature and humidity integrity.
· Enhanced security meeting earthquake resistance standards.
Nitin Navneet Tatiwala, Vice President of FedEx Express, Marketing, Middle East, India Sub-continent & Africa (MEISA) said, “With FedEx having deep expertise in handling critical clinical trial shipments, the launch of FedEx Life Science Center (LSC) will act as a one stop shop for all clinical trial storage and distribution requirements of healthcare customers in India. The new center is in addition to FedEx’s current LSCs in Japan, South Korea, Singapore, the USA, and the Netherlands – making it a global network of storage and distribution depots to support our healthcare and pharmaceutical customers.”
